The value of interprofessional collaboration in dealing with the opioid crisis was highlighted as students and staff from the Jacobs School of Medicine and Biomedical Sciences joined other UB schools of study during a forum on opioid dependence.
Students from the Jacobs School of Medicine and Biomedical Sciences joined hundreds of their UB peers in the health professions, social work, law and management for an interprofessional forum on opioid dependence.
Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has received a $7 million grant to develop an effective way to treat drug users with the hepatitis C virus (HCV).
Jun-Xu Li, MD, PhD, assistant professor of pharmacology and toxicology, has received the Joseph Cochin Young Investigator Award from the College of Problems of Drug Dependence (CPDD) for his research on pharmacotherapy for stimulant abuse.
Torin J. Finver, MD, program director for the Department of Family Medicine’s addiction medicine fellowship, has been appointed to the board of directors for the New York Society of Addiction Medicine (NYSAM).
The risks of the new painkiller Zohydro — an extended-release formulation of hydrocodone — far outweigh the benefits and could lead to more overdoses, according to Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine.
Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine, will direct a new national center aimed at training physicians to address addiction through early intervention and prevention.
With a major grant, family medicine physicians at UB are forming a council that will develop curricula and national standards of excellence for postgraduate medical education programs in addiction medicine.